Back/Quest Diagnostics Recognized Among Fortune's Most Admired Companies for Healthcare Excellence
healthcare·January 23, 2026·dgx

Quest Diagnostics Recognized Among Fortune's Most Admired Companies for Healthcare Excellence

ED
Editorial
Cashu Markets·2 min read
TL;DR
  • Quest Diagnostics ranked on Fortune's 2026 World's Most Admired Companies™ list for the twelfth consecutive year.
  • The company excels in product quality, innovation, and social responsibility, ranking second in its category.
  • Quest Diagnostics provides diagnostic insights to improve health outcomes for one in three adult Americans.

Quest Diagnostics Earns Esteemed Recognition for Excellence in Healthcare Services

Quest Diagnostics, a leading provider of diagnostic information services, continues to affirm its position as an industry leader by securing a spot on Fortune magazine's 2026 World's Most Admired Companies™ list for the twelfth consecutive year. This recognition highlights the unwavering commitment of its 55,000 employees to the company's mission of fostering a healthier world. CEO Jim Davis emphasizes that this accolade is not merely a recognition; it is a testament to the collective efforts of the team in delivering quality healthcare solutions that make a significant impact on public health.

Ranking second in the "Health Care: Pharmacy and Other Services" category, Quest Diagnostics stands out due to its robust reputation built on nine key attributes, including product quality, innovation, and social responsibility. The evaluation process, conducted in collaboration with Korn Ferry, involves surveying thousands of executives, directors, and analysts, assessing nearly 700 companies. This rigorous assessment process ensures that only the highest-performing companies in their respective industries receive such recognition, underscoring Quest's excellence in providing diagnostic services that empower healthcare providers and patients alike.

As a vital player in the healthcare ecosystem, Quest Diagnostics offers diagnostic insights that lead to improved health outcomes. With access to one of the largest databases of de-identified clinical lab results, the company enables the identification and treatment of diseases while promoting healthy behaviors and enhancing healthcare management. By serving approximately one in three adult Americans and half of the physicians and hospitals in the United States, Quest is dedicated to transforming lives through actionable insights derived from laboratory testing, reinforcing its esteemed position within the healthcare sector.

Beyond its recent accolade, Quest Diagnostics continues to innovate in diagnostic technology and services, ensuring that it meets the evolving needs of patients and healthcare providers. The company’s dedication to social responsibility is evident through its efforts to improve health access and outcomes in underserved communities. By focusing on quality and innovation, Quest Diagnostics not only enhances its service offerings but also contributes to a healthier society.

In summary, Quest Diagnostics' recognition on the Fortune list serves as a significant milestone that reflects the company's ongoing commitment to excellence in healthcare. As it continues to lead the way in diagnostic services, the organization remains focused on its mission to deliver quality care and actionable insights that empower both patients and healthcare professionals.

Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...